AlphaYouCRL: Coleman Glenn discloses a purchase
By AlphaYouPublished Form 4
Coleman Glenn
Reporting filer
Coleman Glenn reported Purchase in CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: 10 units of Common Stock, dated 2026-09-30. The full Form 4 contains 1 transaction entry.
- Disclosed
- Oct 2, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Coleman Glenn | 2026-09-30 | P | Purchase | 10 | 297.43 | 27,762 | 2 days | Filed terms
|
Common Stock
- Owner
- Coleman Glenn
- Date
- 2026-09-30
- Code
- P
- Action
- Purchase
- Quantity
- 10
- Price
- 297.43
- Following holdings
- 27,762
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-30
- transaction Form Type: 4
- transaction Code: P
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 10
- id: F1
- transaction Price Per Share: 297.43
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 27762
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Coleman Glenn: EVP & Chief Financial Officer.
- F1: The shares were acquired pursuant to the Company's Employee Stock Purchase Plan at the fair market value of the Company's common stock on the purchase date. The Reporting Person elected to participate in the Plan during an open trading window prior to the commencement of the quarterly purchase period.
Original sources
Prepared automatically from public filing data. Report a correction.